Added to YB: 2024-03-26
Pitch date: 2024-03-26
LCTX:US [bullish]
Lineage Cell Therapeutics, Inc.
+3.91%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, developing cell replacement therapies to treat serious medical conditions in the United States and internationally.
Market Cap
$316.6M
Pitch Price
$1.28
Price Target
N/A
Dividend
N/A
EV/EBITDA
N/A
P/E
-4.46
EV/Sales
17.89
Sector
Biotechnology
Category
N/A
Show full summary:
Lineage Cell Therapeutics, Inc. LCTX:US
A summary for this pitch has not been created yet.
Read full article (0 min)